Cellular HIV‐1 DNA quantitation in patients during simplification therapy with protease inhibitor‐sparing regimens
Loredana Sarmati(University of Rome Tor Vergata), Massimo Andreoni(University of Rome Tor Vergata), Saverio Giuseppe Parisi(University of Padua), Emanuele Nicastri(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Caterina Boldrin(University of Padua), Luca Dori, Anna Rita Buonomini(University of Rome Tor Vergata), Carolina Andreoni(Sapienza University of Rome), Marco Aurélio Echart Montano(Policlinico Tor Vergata), Giorgio Palù(University of Padua), Gabriella d’Ettorre(Policlinico Umberto I), Vincenzo Vullo(Sapienza University of Rome), Francesca Gatti(Brescia University)
Cited by 23
Related Papers
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
|Eurosurveillance|2020|714
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264